Michael R. Costello, MD
Medical Oncology, Hematology
Headshot of Michael R. Costello, MD

Michael R. Costello, MD

Medical Oncology, Hematology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Exton
View 1 additional location
Headshot of Michael R. Costello, MD
Penn Medicine Provider

About me

  • Medical Director. The Abramson Cancer Center West Chester

My education and training

  • Penn State Milton S. Hershey Medical CenterMedical School
  • Temple University HospitalResidency
  • Temple University HospitalFellowship
Watch video featuring Michael R. Costello, MD on YouTube

Spoken languages

English
English

Reviews

Average Rating

1370 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
September 2026
Dr Costello is amazing, he listens and answers all questions.
Anonymous
September 2026
Professionalism
Anonymous
September 2026
Very good at his job managing my disease
Anonymous
September 2026
Very caring and knowledgeable.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Chester County Hospital: Has privileges to treat patients in the hospital.
  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
Dr. Costello is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Cosstello MR, Meropol NJ, Denlinger CS, Engstrom PF, Wright JJ, Li T, McLaughlin S, Beard M, Cimildoro R, Cohen SJ. A phase II trial of the proteasome inhibitor bortezomib in patients with recurrent or metastatic adenocarcinoma of the bile duct or gallbladder (NCI #6135). , Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post Meeting Edition)., 27(155): 2009,e15605


Michael Costello Current Recommendations for Screening for Cervical Cancer , Temple University Hospital Morning Conference Series: 2006


Michael Costello Methicillin Resistant Staph Aureus Infection in a 26 year old patient , Temple University Hospital Morning Conference Series: 2005


Michael Costello Treatment of Thromboembolic Disease in Oncological Patients , Temple University Hospital Morning Conference Series: 2005